See also this year's filing and all EDGAR filings for this company.
PDF Report 0001566044_2021_VYNE_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001566044, VYNE Therapeutics Inc
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 87,259,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 555,000 |
| 3 | remainder_Assets | 5,928,000 |
| 4 | LiabilitiesCurrent | 21,453,000 |
| 5 | LiabilitiesNoncurrent | 34,796,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 1,392,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 424,441,340 |
| 9 | ResearchAndDevelopmentExpense | 33,683,635 |
| 10 | remainder_Expenses | 141,811,000 |
| 11 | remainder_Revenues | 11,278 |
| 12 | remainder_NetIncome | -415,441 |
| 13 | remainder_ComprehensiveNetIncome | 73,883 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 93,742,000 |
| 1 | Liabilities | 56,249,000 |
| 2 | Expenses | 601,327,975 |
| 3 | Revenues | 11,278 |
| 4 | StockholdersEquity | 37,493,000 |
| 5 | NetIncome | -601,732,138 |
| 6 | ComprehensiveNetIncome | -601,695,196 |
| 7 | BaseVar | 375,909,788 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -6.93 |
| 9 | EconomicCapitalRatio | 0.0301 |
Edgar->Model Mapping
Feature Distribution
Change over Time
